Biological Health Risks and Economic Development
NBER Working Paper No. 21277
With populations aging and the epidemic of obesity spreading across the globe, global health risks are shifting toward non-communicable diseases. Innovative biomarker data from recently conducted population-representative surveys in lower, middle and higher income countries are used to describe how four key biological health risks – hypertension, cholesterol, glucose and inflammation – vary with economic development and, within each country, with age, gender and education. As obesity rises in lower income countries, the burden of non-communicable diseases will rise in roughly predictable ways and the costs to society are potentially very large. Investigations that explain cross-country differences in these relationships will have a major impact on advancing understanding of the complex interplay between biology, health and development.
Document Object Identifier (DOI): 10.3386/w21277
Published: "Biological health risks and economic development." in John Komlos and Inas Rashad Kelly (eds.) The Oxford Handbook of Economics and Human Biology, Oxford University Press, 2016
Users who downloaded this paper also downloaded* these: